APRIL CASSADY: Open Payments
NPI 1710228473 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 35 payments from 13 companies in 2025. Trend: 2023 $925 · 2024 $753 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 8 | $158 |
| Mallinckrodt Hospital Products Inc. | 8 | $139 |
| Travere Therapeutics, Inc. | 3 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Janssen Biotech, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| SCPHARMACEUTICALS INC. | 2 | $32 |
| IMMUNITYBIO, INC. | 2 | $29 |
| ABBVIE INC. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
Products named: PURIFIED CORTROPHIN GEL, TERLIVAZ, ACTHAR, Filspari, Kerendia, JARDIANCE, FUROSCIX, ANKTIVA.
Industry payments across VA — which companies pay providers there.
